首页 文献索引 SCI期刊 AI助手
首页 正文

Review Clinical and experimental immunology. 2020 Nov;202(2):162-192. doi: 10.1111/cei.13517 Q23.82025

Vaccines for COVID-19

COVID-19疫苗 翻译改进

J S Tregoning  1, E S Brown  1, H M Cheeseman  1, K E Flight  1, S L Higham  1, N-M Lemm  1, B F Pierce  1, D C Stirling  1, Z Wang  1, K M Pollock  1

作者单位 +展开

作者单位

  • 1 Department of Infectious Disease, St Mary's Campus, Imperial College London, London, UK.

    • DOI: 10.1111/cei.13517 PMID: 32935331

    摘要 Ai翻译

    Since the emergence of COVID-19, caused by the SARS-CoV-2 virus at the end of 2019, there has been an explosion of vaccine development. By 24 September 2020, a staggering number of vaccines (more than 200) had started preclinical development, of which 43 had entered clinical trials, including some approaches that have not previously been licensed for human vaccines. Vaccines have been widely considered as part of the exit strategy to enable the return to p... ...点击完成人机验证后继续浏览
    Copyright © Clinical and experimental immunology. 中文内容为AI机器翻译，仅供参考！

    相关内容

    期刊名：Clinical and experimental immunology

    缩写：CLIN EXP IMMUNOL

    ISSN：0009-9104

    e-ISSN：1365-2249

    IF/分区：3.8/Q2

    文章目录 更多期刊信息

    全文链接
    官方链接
    PMC全文
    引文链接
    复制
    已复制！
    推荐内容
    Vaccines for COVID-19